Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated DailyJoseph P. Eder, Donald Küfe, Lawrence N. Shulman et al.|Journal of Clinical Oncology|2002Cited by 244
Dendritic Cell Myeloma Fusions Stimulate Anti-Tumor Immunity: Results from Pre-Clinical Studies and a Clinical Trial.David Avigan, Donald Küfe, Baldev Vasir et al.|Blood|2004Cited by 5
63: Vaccination with dendritic cell myeloma fusions alone or in conjunction with stem cell transplantation for patients with multiple myelomaDavid Avigan, Donald Küfe, Jacalyn Rosenblatt et al.|Transplantation and Cellular Therapy|2007Cited by 0